And that might not be such a good idea. One week off between chemo infusions is one thing but two weeks off may be something entirely different. Mostly I’m afraid my body will de-acclimate from the … more →
Michael's BlogAACR Communications Staff wrote 3 weeks ago: PHILADELPHIA – Pancreatic cancer remains one of the deadliest and hardest to treat cancers. Af … more →
aimgrrrl wrote 1 month ago: After my long hiatus, I’m going to try to catch you all up on what’s been going on. Defi … more →
smnewsletters wrote 4 months ago: A new study from Norway suggests a treatment alternative to avoid gemcitabine toxicity in NSCLC. A d … more →
Paul Cacciatore wrote 5 months ago: The 2009 American Society of Clinical Oncology (ASCO) Annual Meeting was held in Orlando, Florida fr … more →
drnyssa wrote 6 months ago: Cancer treatments commonly use one or more of the following methods: chemotherapy, radiation therapy … more →
Michael wrote 6 months ago: And that might not be such a good idea. One week off between chemo infusions is one thing but two w … more →
Michael wrote 8 months ago: Today was infusion day and I received my week’s ration of Gemcitabine or as we know it Gemzar. Some … more →
purplefish001 wrote 8 months ago: Let me start by saying that apparently people are reading this blog. For those of you that are tryin … more →
Paul Cacciatore wrote 9 months ago: “… Compared with standard paclitaxel and carboplatin, addition of a third cytotoxic agen … more →
healtherm2 wrote 11 months ago: SAN ANTONIO – NabTM-paclitaxel (Abraxane), used in tandem with gemcitabine and epirubicin, is … more →
Michael wrote 11 months ago: Marvina and I had a very difficult discussion last night. It was particularly hard for her. She … more →
bmirtsching wrote 11 months ago: Paclitaxel (Taxol) chemotherapy in combination with Bevacizumab (Avastin) has become a standard trea … more →
Michael wrote 11 months ago: It’s late afternoon and my Oncologist just called with the test results. The bone scan was no … more →
Paul Cacciatore wrote 1 year ago: “In women with recurrent ovarian cancer, treatment with topotecan along with etoposide or gemc … more →
whipplelife wrote 1 year ago: Research is ongoing about how to treat pancreatic cancer and different approaches are taken at vario … more →
Mike wrote 1 year ago: PURPOSE: Pemetrexed and gemcitabine have single-agent activity in malignant pleural mesothelioma (MP … more →
bmirtsching wrote 2 years ago: The NSABP (National Surgical Adjuvant Breast Project) B-40 Study of new drug combinations, sequence, … more →